Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho Rejects Requests for Expanded Participation in Structural Reform Zones
January 19, 2004
- Takeda's Blopress Aims for 40% Share in ARB Market
January 19, 2004
- Births Down 3rd Year in a Row, Hit Historic Low in 2003: Vital Statistics
January 19, 2004
- Diovan Enjoys Steady Growth, Sales of \60 Bil. in 2003
January 19, 2004
- REGULATORY NEWS IN BRIEF
January 19, 2004
- Kyowa Hakko to Strengthen Promotion of Allergy Treatment Allelock
January 19, 2004
- Sumitomo Working to Increase Zyrtec's Share to 7%
January 19, 2004
- New Year's Meeting Held by 4 Drug Industry Organizations in Tokyo
January 19, 2004
- Brand Image Still Hinders Acceptance of GE Drugs: PJ, So-net M3 Survey
January 19, 2004
- FY 2004 Business Plan Approved: JPMA General Assembly
January 19, 2004
- BUSINESS NEWS IN BRIEF
January 19, 2004
- CORPORATE ROUNDUP NEWS IN BRIEF
January 19, 2004
- AstraZeneca Integrates R&D in Japan into AZ Global Development
January 19, 2004
- WEBSITE NEWS
January 19, 2004
- 1 in 3 Glaucoma Patients Has Poor Compliance: Patient Body Survey
January 19, 2004
- Expecting Better Allocation of Medical Fees in FY2004: Health Minister
January 19, 2004
- MEDICAL DEVICE NEWS IN BRIEF
January 19, 2004
- Dr Sakaguchi Appeals for Steps to Prevent Medical Accidents
January 19, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 19, 2004
- Korosho to Establish System to More Quickly Approve New Indications: PFSB DG
January 19, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…